DrugPatentWatch Database Preview
INFLAMASE MILD Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which patents cover Inflamase Mild, and what generic alternatives are available?
Inflamase Mild is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in INFLAMASE MILD is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
Summary for INFLAMASE MILD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 39 |
Patent Applications: | 3,993 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INFLAMASE MILD at DailyMed |

Synonyms for INFLAMASE MILD
[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] dihydrogen phosphate |
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(disodium phosphate) |
125-02-0 |
1263143-23-2 |
A805337 |
AC1L1J72 |
AC1L1LDT |
AC1L9B41 |
AKOS025310687 |
AKOS025394281 |
AN-14017 |
API0003920 |
AT-2935 |
BCP11881 |
C21H27O8P.2Na |
CHEMBL1201014 |
Codelsol |
Cortisate-20 (Veterinary) |
CS-2878 |
CTK8I0968 |
D00981 |
D3918 |
disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl] phosphate |
disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] phosphate |
disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] phosphate |
disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate |
Disodium prednisolone 21-phosphate |
disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate |
DTXSID2047480 |
EINECS 204-722-9 |
EINECS 206-120-1 |
FT-0631728 |
HY-B0645 |
Hydeltrasol |
I06-0770 |
Inflamase |
Inflamase Forte |
IV021NXA9J |
KB-296232 |
LS-118502 |
LS-174283 |
Metreton |
Millipred |
MolPort-019-991-120 |
NCGC00249889-01 |
Optimyd |
Optival |
Pediapred (TN) |
Phortisolone |
Predair |
Predair Forte |
Prednesol |
Prednisolone (disodium phosphate) |
Prednisolone 21-(dihydrogen phosphate) |
Prednisolone 21-(disodium phosphate) |
Prednisolone 21-phosphate disodium |
Prednisolone 21-Phosphate Disodium Salt |
Prednisolone disodium phosphate |
Prednisolone phosphate sodium |
prednisolone sodium phosphate |
Prednisolone sodium phosphate (JP17/USP) |
Prednisolone Sodium Phosphate [USAN:JAN] |
Prednisolone sodium phosphate [USP:JAN] |
Predsol |
Predsolan |
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate), disodium salt |
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate),disodium salt |
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11.beta.)- |
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11beta)- |
Prozorin |
SCHEMBL1650407 |
SCHEMBL23563 |
Sodium prednisolone phosphate |
Solucort |
ST24049032 |
UNII-IV021NXA9J |
VA11575 |
Vasocidin Solution |
Veripred 20 |
US Patents and Regulatory Information for INFLAMASE MILD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | INFLAMASE MILD | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 080751-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |